GSK kept quiet about cancer risks of heartburn drug Zantac for 40 years – Bloomberg

Feb. 16, 2023 11:30 AM ETGSK plc (GSK)PFE, SNY, SNYNFBy: Dulan Lokuwithana, SA News Editor29 Comments

Zantac 150


Update: Feb. 16, 11.30AM EST: Adds comments from GSK (NYSE:GSK)

GSK (GSK) American Depository Shares lost ~2% pre-market Wednesday after a new report from Bloomberg Businessweek claimed that the British drugmaker chose to keep quiet on

Recommended For You

Comments (29)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.